Potential Roles of mtDNA Mutations in PCOS-IR: A Review
Xiao-Chao Dong,Chang Liu,Guang-Chao Zhuo,Yu Ding
DOI: https://doi.org/10.2147/DMSO.S393960
2023-01-25
Abstract:Xiao-Chao Dong, 1 Chang Liu, 1 Guang-Chao Zhuo, 2 Yu Ding 2 1 Department of Gynecology and Obstetrics, Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China; 2 Central Laboratory, Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China Correspondence: Yu Ding, Central Laboratory, Hangzhou First People's Hospital, Zhejiang University School of Medicine, 261 Huansha Road, Hangzhou, People's Republic of China, Tel/Fax +86-571-5600-5600, Email Polycystic ovary syndrome (PCOS) is the most common heterogeneous endocrine disease that affecting females in reproductive age. Insulin resistance (IR), an important molecular basis for PCOS, accounts for at least 75% of women carrying this syndrome. Although there have been many studies on PCOS-IR, the detailed mechanisms are not fully understood. As essential hub for energy generation, mitochondria are critical to insulin secretion and normal function, whereas mutations in mitochondrial DNA (mtDNA) result in mitochondrial dysfunctions contributing to the pathophysiology of PCOS-IR via the regulation of balance of oxidative stress (OS), energy deficiency, or hormone metabolism. In the current review, we summarize the clinical and molecular features of PCOS-IR and discuss molecular mechanisms related to mtDNA mutations. Keywords: PCOS-IR, mitochondrial dysfunction, mtDNA mutations Polycystic ovary syndrome (PCOS) is the most common endocrine disease occurring during reproductive years. It was a kind of endocrine and metabolic disorders that results in obesity, irregularity of menstruation, OS, hyperinsulinemia, hyperandrogenism, infertility, and sterility. 1,2 First identified in 1935, PCOS was also recognized as Stein–Leventhal syndrome. 3 Diagnosis of PCOS in adults can be made when at least two of three criteria are met: impairment of ovarian function, clinical and/or biochemical hyperandrogenism, and polycystic ovaries. 4,5 Despite significant progress in diagnostic criteria for PCOS, the syndrome is still underdiagnosed or misunderstood by many practitioners. 6 In the early stage, PCOS is often complicated with infertility and adverse pregnancy outcomes, while in the long term, the incidence of endometrial cancer, type 2 diabetes mellitus (T2DM), and cardiovascular diseases gradually increase, seriously harming women's physical and mental health. Based on the National Institutes of Health's diagnostic criteria, the geographical prevalence of this disease is 8.7%, 17.8%, and 12% based on the definition proposed by the Androgen Excess and PCOS Society. 7 In a 2019 study, the prevalence of PCOS in Chinese women of reproductive age was 5.6%, which was consistent with other studies, 8 while its incidence in Indian women was 9.13% according to a recent study. 9 Interestingly, PCOS seems to be more frequent in black women (8.0%) than white women (4.8%), with an incidence of 6.6%. 10 The prevalence of oligoanovulation and hyperandrogenemia is 56.6% and 60% among women with PCOS, respectively. 11 Multiple morbidities are linked to PCOS, such as infertility, impairment of glucose tolerance, T2DM, coronary heart disease, depression, gynecological oncology, and nonalcoholic fatty-liver disease. 12 Despite these well-characterized phenotypes, the pathogenesis of PCOS remains unclear. Increasing evidence suggests that genetic, epigenetic, and environmental factors contribute to PCOS progression. 13 However, it was generally accepted that IR and hyperandrogenism play key roles in its etiology. 14 Insulin is the master regulator of glucose metabolism. This hormone works under the condition of glucose uptake by insulin-sensitive tissue (muscle, liver, and adipose). 15,16 IR is caused by defects in insulin signaling, reducing the ability of insulin to stimulate glucose utilization, and can thus lead to high insulin levels (hyperinsulinemia). It has been suggested that >75% of patients have associated IR. 17 At the molecular level, IR and hyperinsulinemia may stimulate P450c17α and influence the activity of 17-hydroxylase and 17,20-lyase. 18 Subsequently, these biochemical processes promote the secretion of androgen, increase free-androgen levels, and inhibit insulin signal transduction and translocation of glucose transporter 4, which affects glucose and lipid metabolism. 19 Androgens can produce IR by directly affecting insulin action in skeletal muscle and adipose tissue, changing adipokine secretion and increasing visceral adiposity. Moreover, insulin and IGF1 20 synergize with luteinizing hormone (LH). 21 Hyperinsulinemia enhanc -Abstract Truncated-
endocrinology & metabolism